METHODS OF USING IL-21 FOR ADOPTIVE IMMUNOTHERAPY AND IDENTIFICATION OF TUMOR ANTIGENS
First Claim
1. A method for identifying a tumor antigen comprising:
- co-culturing tumor material isolated from a subject with peripheral blood mononuclear cells (PBMCs) in the presence of an IL-21 composition and antigen presenting cells (APCs);
isolating a T cell population from the culture;
cloning individual T cells from the T cell population; and
characterizing T cell clones for antigen-specificity.
2 Assignments
0 Petitions
Accused Products
Abstract
Methods for preparing ex vivo T cell cultures using IL-21 compositions for use in adoptive immunotherapy are described. Addition of IL-21 to cultures of non-terminally differentiated T cells population, either isolated or present in peripheral blood mononuclear cells are exposed to one or more tumor antigens, and in the presence of IL-21 compositions and antigen presenting cells (APCs), the resulting T cell population has an enhanced antigen-specificity, and can be reintroduced into the patient. Methods are also disclosed for identifying tumor antigens by culturing T cell populations exposed to IL-21 compositions and APCs in the presence of tumor material.
1 Citation
17 Claims
-
1. A method for identifying a tumor antigen comprising:
-
co-culturing tumor material isolated from a subject with peripheral blood mononuclear cells (PBMCs) in the presence of an IL-21 composition and antigen presenting cells (APCs); isolating a T cell population from the culture; cloning individual T cells from the T cell population; and characterizing T cell clones for antigen-specificity. - View Dependent Claims (2, 3, 4, 5, 6)
-
-
7. A method of preparing a naive CD8+ human T cell population for in use adoptive immunotherapy comprising:
-
isolating peripheral blood mononuclear cells (PBMCs) from a biological sample; identifying PBMCs having a histocompatible phenotype to a subject having a tumor; isolating a naï
ve CD8+ human T cell population;co-culturing tumor material isolated from the subject with the naï
ve CD8+ human T cell population in the presence of an IL-21 composition and antigen presenting cells (APCs); andexpanding the cells in culture. - View Dependent Claims (8, 9)
-
-
10. A method of preparing a naï
- ve CD8+ human T cell population for use in adoptive immunotherapy comprising;
isolating a biological sample containing T cells; identifying a T cell population having a histocompatible phenotype to a subject having a tumor; isolating a naï
ve CD8+ human T cell population;co-culturing tumor material from the subject with the naï
ve CD8+ human T cell population in the presence of an IL-21 composition and APCs; andexpanding these cells in culture. - View Dependent Claims (11, 12, 13)
- ve CD8+ human T cell population for use in adoptive immunotherapy comprising;
-
14. A method for ex vivo expansion of antigen-specific cytotoxic T cells comprising:
-
isolating a biological sample containing T cells; identifying a T cell population having a histocompatible phenotype to a subject; co-culturing antigenic material from the subject with the T cell population in the presence of an IL-21 composition; expanding the cells in culture; and and reintroducing the cells back into the subject. - View Dependent Claims (15)
-
-
16. A method of preparing a non-terminally differentiated CD8+ human T cell population for use in adoptive immunotherapy comprising:
-
isolating a biological sample containing T cells; identifying a T cell population having a histocompatible phenotype to a subject having a tumor; isolating a non-terminally differentiated CD8+ human T cell population; co-culturing tumor material from the subject with the non-terminally differentiated CD8+ human T cell population in the presence of an IL-21 composition and APCs; and expanding these cells in culture. - View Dependent Claims (17)
-
Specification